(RXL) Rexel S.A - Ratings and Ratios
Electrical, Automation, Lighting, Security, Solar
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.50% |
| Yield on Cost 5y | 10.86% |
| Yield CAGR 5y | 27.09% |
| Payout Consistency | 65.8% |
| Payout Ratio | 142.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 33.0% |
| Value at Risk 5%th | 53.3% |
| Relative Tail Risk | -1.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.11 |
| Alpha | 33.53 |
| CAGR/Max DD | 0.78 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.409 |
| Beta | 0.301 |
| Beta Downside | 0.517 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.53% |
| Mean DD | 8.23% |
| Median DD | 7.48% |
Description: RXL Rexel S.A January 06, 2026
Rexel S.A. (ticker RXL) distributes a broad portfolio of low- and ultra-low-voltage electrical products across residential, commercial and industrial markets in France, the rest of Europe, North America and Asia-Pacific. Its catalogue spans smart sensors, lighting, HVAC, fire-safety gear, solar modules, EV-charging equipment, automation components and related software solutions that support construction, renovation, maintenance and production activities.
Key recent metrics show FY 2023 revenue of roughly €13.5 billion with an EBITDA margin of about 5 %, reflecting modest profitability in a highly competitive distribution sector. Growth is being driven by the EU’s green-energy transition-particularly demand for heat-pumps, solar inverters and electric-vehicle chargers-and by the acceleration of digital-enabled services such as remote monitoring and smart-building platforms. However, the business remains sensitive to construction-sector cycles and to supply-chain disruptions in semiconductor components.
For a deeper dive into Rexel’s valuation nuances, the ValueRay platform offers a concise, data-driven analysis worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (247.6m TTM) > 0 and > 6% of Revenue (6% = 1.17b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -2.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 10.22% (prev 13.99%; Δ -3.77pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 707.1m > Net Income 247.6m (YES >=105%, WARN >=100%) |
| Net Debt (4.39b) to EBITDA (1.19b) ratio: 3.70 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.42 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (296.4m) change vs 12m ago -1.72% (target <= -2.0% for YES) |
| Gross Margin 24.86% (prev 25.09%; Δ -0.23pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 137.9% (prev 134.8%; Δ 3.13pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.48 (EBITDA TTM 1.19b / Interest Expense TTM 194.1m) >= 6 (WARN >= 3) |
Altman Z'' 2.74
| (A) 0.14 = (Total Current Assets 6.75b - Total Current Liabilities 4.76b) / Total Assets 14.06b |
| (B) 0.24 = Retained Earnings (Balance) 3.32b / Total Assets 14.06b |
| (C) 0.08 = EBIT TTM 1.06b / Avg Total Assets 14.09b |
| (D) 0.52 = Book Value of Equity 4.60b / Total Liabilities 8.92b |
| Total Rating: 2.74 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 52.99
| 1. Piotroski 4.50pt |
| 2. FCF Yield 3.92% |
| 3. FCF Margin 2.89% |
| 4. Debt/Equity 0.94 |
| 5. Debt/Ebitda 3.70 |
| 6. ROIC - WACC (= 3.08)% |
| 7. RoE 4.63% |
| 8. Rev. Trend -23.92% |
| 9. EPS Trend -25.51% |
What is the price of RXL shares?
Over the past week, the price has changed by -2.57%, over one month by +0.18%, over three months by +16.16% and over the past year by +38.50%.
Is RXL a buy, sell or hold?
What are the forecasts/targets for the RXL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32.3 | -2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 45.2 | 37% |
RXL Fundamental Data Overview January 03, 2026
Market Cap EUR = 9.94b (9.94b EUR * 1.0 EUR.EUR)
P/E Trailing = 40.3095
P/E Forward = 12.21
P/S = 0.5115
P/B = 1.9203
P/EG = 0.97
Beta = 1.067
Revenue TTM = 19.43b EUR
EBIT TTM = 1.06b EUR
EBITDA TTM = 1.19b EUR
Long Term Debt = 2.35b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.24b EUR (from shortTermDebt, last quarter)
Debt = 4.83b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.39b EUR (from netDebt column, last quarter)
Enterprise Value = 14.33b EUR (9.94b + Debt 4.83b - CCE 439.3m)
Interest Coverage Ratio = 5.48 (Ebit TTM 1.06b / Interest Expense TTM 194.1m)
FCF Yield = 3.92% (FCF TTM 561.8m / Enterprise Value 14.33b)
FCF Margin = 2.89% (FCF TTM 561.8m / Revenue TTM 19.43b)
Net Margin = 1.27% (Net Income TTM 247.6m / Revenue TTM 19.43b)
Gross Margin = 24.86% ((Revenue TTM 19.43b - Cost of Revenue TTM 14.60b) / Revenue TTM)
Gross Margin QoQ = 25.03% (prev 25.03%)
Tobins Q-Ratio = 1.02 (Enterprise Value 14.33b / Total Assets 14.06b)
Interest Expense / Debt = 1.00% (Interest Expense 48.4m / Debt 4.83b)
Taxrate = 34.46% (68.8m / 199.5m)
NOPAT = 697.5m (EBIT 1.06b * (1 - 34.46%))
Current Ratio = 1.42 (Total Current Assets 6.75b / Total Current Liabilities 4.76b)
Debt / Equity = 0.94 (Debt 4.83b / totalStockholderEquity, last quarter 5.13b)
Debt / EBITDA = 3.70 (Net Debt 4.39b / EBITDA 1.19b)
Debt / FCF = 7.82 (Net Debt 4.39b / FCF TTM 561.8m)
Total Stockholder Equity = 5.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.76% (Net Income 247.6m / Total Assets 14.06b)
RoE = 4.63% (Net Income TTM 247.6m / Total Stockholder Equity 5.35b)
RoCE = 13.83% (EBIT 1.06b / Capital Employed (Equity 5.35b + L.T.Debt 2.35b))
RoIC = 8.08% (NOPAT 697.5m / Invested Capital 8.63b)
WACC = 5.01% (E(9.94b)/V(14.77b) * Re(7.12%) + D(4.83b)/V(14.77b) * Rd(1.00%) * (1-Tc(0.34)))
Discount Rate = 7.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.87%
[DCF Debug] Terminal Value 77.06% ; FCFE base≈696.2m ; Y1≈642.5m ; Y5≈580.5m
Fair Price DCF = 35.57 (DCF Value 10.43b / Shares Outstanding 293.3m; 5y FCF grow -9.72% → 3.0% )
EPS Correlation: -25.51 | EPS CAGR: -39.48% | SUE: 0.0 | # QB: 0
Revenue Correlation: -23.92 | Revenue CAGR: 6.82% | SUE: 0.02 | # QB: 0
EPS next Year (2026-12-31): EPS=2.55 | Chg30d=+0.004 | Revisions Net=+1 | Growth EPS=+15.4% | Growth Revenue=+2.9%